Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-308091
Filing Date
2025-12-04
Accepted
2025-12-04 16:15:03
Documents
1
Period of Report
2025-12-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3468
  Complete submission text file 0001193125-25-308091.txt   4896
Mailing Address 1599 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 1599 INDUSTRIAL ROAD SAN CARLOS CA 94070 (650) 980-9099
Biomea Fusion, Inc. (Issuer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOMEA FUSION, INC. 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address
Hitchcock Michael J.M. (Reporting) CIK: 0001856674 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40335 | Film No.: 251549537